Bayer Buys Cancer-Fighting Antibody Rights For $426M
Bayer Schering Pharma AG on Tuesday exercised an option to buy the rights to an innovative cancer treatment from American biopharmaceutical company Micromet Inc. for as much as $426 million....To view the full article, register now.
Already a subscriber? Click here to view full article